_version_ 1784739894565797888
author Shi, Tingyan
Xiang, Libing
Zhu, Jianqing
Liu, Jihong
Zhang, Ping
Wang, Huaying
Feng, Yanling
Zhu, Tao
Zhang, Yingli
Yu, Aijun
Jiang, Wei
Wang, Xipeng
Zhu, Yaping
Wu, Sufang
Teng, Yincheng
Zhang, Jiejie
Jiang, Rong
Zhang, Wei
Jia, Huixun
Zang, Rongyu
author_facet Shi, Tingyan
Xiang, Libing
Zhu, Jianqing
Liu, Jihong
Zhang, Ping
Wang, Huaying
Feng, Yanling
Zhu, Tao
Zhang, Yingli
Yu, Aijun
Jiang, Wei
Wang, Xipeng
Zhu, Yaping
Wu, Sufang
Teng, Yincheng
Zhang, Jiejie
Jiang, Rong
Zhang, Wei
Jia, Huixun
Zang, Rongyu
author_sort Shi, Tingyan
collection PubMed
description
format Online
Article
Text
id pubmed-9250854
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-92508542022-07-06 Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study Shi, Tingyan Xiang, Libing Zhu, Jianqing Liu, Jihong Zhang, Ping Wang, Huaying Feng, Yanling Zhu, Tao Zhang, Yingli Yu, Aijun Jiang, Wei Wang, Xipeng Zhu, Yaping Wu, Sufang Teng, Yincheng Zhang, Jiejie Jiang, Rong Zhang, Wei Jia, Huixun Zang, Rongyu J Gynecol Oncol Addendum Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022-06-07 /pmc/articles/PMC9250854/ /pubmed/35775688 http://dx.doi.org/10.3802/jgo.2022.33.e63 Text en Copyright © 2022. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Addendum
Shi, Tingyan
Xiang, Libing
Zhu, Jianqing
Liu, Jihong
Zhang, Ping
Wang, Huaying
Feng, Yanling
Zhu, Tao
Zhang, Yingli
Yu, Aijun
Jiang, Wei
Wang, Xipeng
Zhu, Yaping
Wu, Sufang
Teng, Yincheng
Zhang, Jiejie
Jiang, Rong
Zhang, Wei
Jia, Huixun
Zang, Rongyu
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
title Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
title_full Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
title_fullStr Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
title_full_unstemmed Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
title_short Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
title_sort addendum: a phase ii trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: sgog soc-3 study
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250854/
https://www.ncbi.nlm.nih.gov/pubmed/35775688
http://dx.doi.org/10.3802/jgo.2022.33.e63
work_keys_str_mv AT shitingyan addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT xianglibing addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhujianqing addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT liujihong addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhangping addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT wanghuaying addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT fengyanling addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhutao addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhangyingli addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT yuaijun addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT jiangwei addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT wangxipeng addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhuyaping addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT wusufang addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT tengyincheng addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhangjiejie addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT jiangrong addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zhangwei addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT jiahuixun addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study
AT zangrongyu addendumaphaseiitrialofcytoreductivesurgerycombinedwithniraparibmaintenanceinplatinumsensitivesecondaryrecurrentovariancancersgogsoc3study